Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 3/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.35 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.35 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 10/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.34 |
| ▸ | RARA | P10276 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | FABP7 | O15540 | 1/20 | 0.33 |
| ▸ | FABP3 | P05413 | 1/20 | 0.33 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19624483 | 0.88 | KDM4E (0.34) | PTGER4PTGER3PTGER1PTGER2FFAR4 | |
| SCHEMBL19804602 | 0.88 | EGFR (0.35) | SLC6A9PTGER4PTGER3PTGER1PTGER2 | |
| SCHEMBL19797155 | 0.82 | PTPN11 (0.34) | FFAR4RARARARBRARG | |
| SCHEMBL19804500 | 0.80 | SLC6A9 (0.45) | SLC6A9RARARARBRARG | |
| SCHEMBL19797154 | 0.80 | RARB (0.34) | RARARARBRARG | |
| SCHEMBL19804366 | 0.78 | RARB (0.45) | SLC6A9RARARARBRARGMCL1 | |
| SCHEMBL19804806 | 0.78 | RARA (0.37) | SLC6A9MTNR1AMTNR1BFFAR4FFAR1 | |
| SCHEMBL19804711 | 0.78 | PTGER1 (0.44) | PTGER4PTGER3PTGER1PTGER2FFAR4 | |
| SCHEMBL19804476 | 0.78 | RARB (0.41) | SLC6A9RARARARBRARGMCL1 | |
| SCHEMBL19804604 | 0.78 | POLB (0.44) | PTGER4PTGER3FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | SLC6A9 2938/4885PTGER4 2215/4885PTGER3 3498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.